Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 474 entries
Sorted by: Best Match Show Resources per page
Organisational sustainability modelling for return on investment (ROI): Case studies presented by a national health service (NHS) trust UK

case studies

Chang V, De D, Wills G.
GSID: GQP8jUxZHjAJ
V Chang, D De Roure, G Wills… - Journal of Computing …, 2011 - hrcak.srce.hr

… We illustrate its use with two case studies. The first case study concerns a National Health Service (NHS) Trust UK Infrastructure and confirms … The second case study shows 3D Visualisation being used to confirm incremental improvements to...

Cite
Chang, V., De Roure, D., Wills, G., John Walters, R., & Barry, T. (2011). Organisational sustainability modelling for return on investment (ROI): Case studies presented by a national health service (NHS) trust UK. Journal of Computing and Information Technology, 19(3), 177-192.
Chang, Victor, et al. "Organisational sustainability modelling for return on investment (ROI): Case studies presented by a national health service (NHS) trust UK." Journal of Computing and Information Technology 19.3 (2011): 177-192.
Copy Download .nbib Format: MLA
Language development in the pre-school years

Pre-school

Wells G.
GSID: 62UWk6lmlCMJ
G Wells, W Gordon - 1985 - books.google.com

After more than a decade of research the Bristol Study of Language Development has assembled a corpus of data on the language development of children aged one to five years that is representative both in terms of the sample...

Cite
Wells, G., & Gordon, W. (1985). Language development in the pre-school years (Vol. 2). CUP Archive.
Wells, Gordon, and Wells Gordon. Language development in the pre-school years. Vol. 2. CUP Archive, 1985.
Copy Download .nbib Format: MLA
[Prognosis, periods of hospitalization and work disability in type I diabetes mellitus].

Lebensversicherungs Medizin

Willms G, Berger M.
PMID: 2891007
Lebensversicher Med. 1987 Nov 01;39(6):169-72.

No abstract available.

Cite
Willms G, Berger M. Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicher Med. 1987;39(6):169-72
Willms, G., & Berger, M. (1987). Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicherungs Medizin, 39(6), 169-72.
Willms, G, and Berger, M. "Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I." [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicherungs Medizin vol. 39,6 (1987): 169-72.
Willms G, Berger M. Prognose, Krankenhausaufenthalts- und Arbeitsunfähigkeits-Zeiten bei Diabetes mellitus vom Typ I. [Prognosis, periods of hospitalization and work disability in type I diabetes mellitus]. Lebensversicher Med. 1987 Nov 01;39(6):169-72. German. PMID: 2891007.
Copy Download .nbib Format: NLM
Have knowledge, will travel.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Miles G.
PMID: 2521148
Nurs Stand. 1989 May 20;3(34):26-7. doi: 10.7748/ns.3.34.26.s42.

No abstract available.

Cite
Miles G. Have knowledge, will travel. Nurs Stand. 1989;3(34):26-7doi: 10.7748/ns.3.34.26.s42.
Miles, G. (1989). Have knowledge, will travel. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 3(34), 26-7. https://doi.org/10.7748/ns.3.34.26.s42
Miles, G. "Have knowledge, will travel." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 3,34 (1989): 26-7. doi: https://doi.org/10.7748/ns.3.34.26.s42
Miles G. Have knowledge, will travel. Nurs Stand. 1989 May 20;3(34):26-7. doi: 10.7748/ns.3.34.26.s42. PMID: 2521148.
Copy Download .nbib Format: NLM
High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread.

The journal of pathology. Clinical research

Sgaramella N, Lindell Jonsson E, Boldrup L, Califano L, Coates PJ, Tartaro G, Lo Muzio L, Fåhraeus R, Colella G, Dell'Aversana Orabona G, Loljung L, Santagata M, Rossiello R, Wilms T, Danielsson K, Laurell G, Nylander K.
PMID: 27499910
J Pathol Clin Res. 2015 Oct 09;2(1):3-8. doi: 10.1002/cjp2.28. eCollection 2016 Jan.

More than 30% of patients with squamous cell carcinoma (SCC) of the mobile tongue have clinically undetectable lymph node metastasis. Tumour cells can spread as single cells or collectively. A protein known to play a role in both processes...

Cite
Sgaramella N, Lindell Jonsson E, Boldrup L, et al. High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread. J Pathol Clin Res. 2015;2(1):3-8doi: 10.1002/cjp2.28.
Sgaramella, N., Lindell Jonsson, E., Boldrup, L., Califano, L., Coates, P. J., Tartaro, G., Lo Muzio, L., Fåhraeus, R., Colella, G., Dell'Aversana Orabona, G., Loljung, L., Santagata, M., Rossiello, R., Wilms, T., Danielsson, K., Laurell, G., & Nylander, K. (2016). High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread. The journal of pathology. Clinical research, 2(1), 3-8. https://doi.org/10.1002/cjp2.28
Sgaramella, Nicola, et al. "High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread." The journal of pathology. Clinical research vol. 2,1 (2016): 3-8. doi: https://doi.org/10.1002/cjp2.28
Sgaramella N, Lindell Jonsson E, Boldrup L, Califano L, Coates PJ, Tartaro G, Lo Muzio L, Fåhraeus R, Colella G, Dell'Aversana Orabona G, Loljung L, Santagata M, Rossiello R, Wilms T, Danielsson K, Laurell G, Nylander K. High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread. J Pathol Clin Res. 2015 Oct 09;2(1):3-8. doi: 10.1002/cjp2.28. eCollection 2016 Jan. PMID: 27499910; PMCID: PMC4858125.
Copy Download .nbib Format: NLM
MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.

Oncotarget

Wilms C, Kroeger CM, Hainzl AV, Banik I, Bruno C, Krikki I, Farsam V, Wlaschek M, Gatzka MV.
PMID: 28978033
Oncotarget. 2017 Jun 27;8(40):67287-67299. doi: 10.18632/oncotarget.18617. eCollection 2017 Sep 15.

Histone modifying enzymes, such as histone deacetylases (HDACs) and polycomb repressive complex (PRC) components, have been implicated in regulating tumor growth, epithelial-mesenchymal transition, tumor stem cell maintenance, or repression of tumor suppressor genes - and may be promising targets...

Cite
Wilms C, Kroeger CM, Hainzl AV, et al. MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth. Oncotarget. 2017;8(40):67287-67299doi: 10.18632/oncotarget.18617.
Wilms, C., Kroeger, C. M., Hainzl, A. V., Banik, I., Bruno, C., Krikki, I., Farsam, V., Wlaschek, M., & Gatzka, M. V. (2017). MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth. Oncotarget, 8(40), 67287-67299. https://doi.org/10.18632/oncotarget.18617
Wilms, Christina, et al. "MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth." Oncotarget vol. 8,40 (2017): 67287-67299. doi: https://doi.org/10.18632/oncotarget.18617
Wilms C, Kroeger CM, Hainzl AV, Banik I, Bruno C, Krikki I, Farsam V, Wlaschek M, Gatzka MV. MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth. Oncotarget. 2017 Jun 27;8(40):67287-67299. doi: 10.18632/oncotarget.18617. eCollection 2017 Sep 15. PMID: 28978033; PMCID: PMC5620173.
Copy Download .nbib Format: NLM
Electrochemical performance of MXenes as K-ion battery anodes.

Chemical communications (Cambridge, England)

Naguib M, Adams RA, Zhao Y, Zemlyanov D, Varma A, Nanda J, Pol VG.
PMID: 28607970
Chem Commun (Camb). 2017 Jun 22;53(51):6883-6886. doi: 10.1039/c7cc02026k.

Herein, we report on the electrochemical performance of two-dimensional transition metal carbonitrides as novel promising electrode materials in K-ion batteries. Titanium carbonitride, Ti

Cite
Naguib M, Adams RA, Zhao Y, et al. Electrochemical performance of MXenes as K-ion battery anodes. Chem Commun (Camb). 2017;53(51):6883-6886doi: 10.1039/c7cc02026k.
Naguib, M., Adams, R. A., Zhao, Y., Zemlyanov, D., Varma, A., Nanda, J., & Pol, V. G. (2017). Electrochemical performance of MXenes as K-ion battery anodes. Chemical communications (Cambridge, England), 53(51), 6883-6886. https://doi.org/10.1039/c7cc02026k
Naguib, Michael, et al. "Electrochemical performance of MXenes as K-ion battery anodes." Chemical communications (Cambridge, England) vol. 53,51 (2017): 6883-6886. doi: https://doi.org/10.1039/c7cc02026k
Naguib M, Adams RA, Zhao Y, Zemlyanov D, Varma A, Nanda J, Pol VG. Electrochemical performance of MXenes as K-ion battery anodes. Chem Commun (Camb). 2017 Jun 22;53(51):6883-6886. doi: 10.1039/c7cc02026k. PMID: 28607970.
Copy Download .nbib Format: NLM
A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Miles G, Leonard SA, Ghosh N, Premchand P.
PMID: 27200761
Value Health. 2014 Nov;17(7):A365. doi: 10.1016/j.jval.2014.08.814. Epub 2014 Oct 26.

No abstract available.

Cite
Miles G, Leonard SA, Ghosh N, et al. A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective. Value Health. 2014;17(7):A365doi: 10.1016/j.jval.2014.08.814.
Miles, G., Leonard, S. A., Ghosh, N., & Premchand, P. (2014). A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A365. https://doi.org/10.1016/j.jval.2014.08.814
Miles, G, et al. "A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A365. doi: https://doi.org/10.1016/j.jval.2014.08.814
Miles G, Leonard SA, Ghosh N, Premchand P. A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective. Value Health. 2014 Nov;17(7):A365. doi: 10.1016/j.jval.2014.08.814. Epub 2014 Oct 26. PMID: 27200761.
Copy Download .nbib Format: NLM
The Etiology of Kala-Azar.

The Indian medical gazette

Giles G.
PMID: 29001726
Ind Med Gaz. 1898 Jan;33(1):1-4.

No abstract available.

Cite
Giles G. The Etiology of Kala-Azar. Ind Med Gaz. 1898;33(1):1-4
Giles, G. (1898). The Etiology of Kala-Azar. The Indian medical gazette, 33(1), 1-4.
Giles, G. "The Etiology of Kala-Azar." The Indian medical gazette vol. 33,1 (1898): 1-4.
Giles G. The Etiology of Kala-Azar. Ind Med Gaz. 1898 Jan;33(1):1-4. PMID: 29001726; PMCID: PMC5140915.
Copy Download .nbib Format: NLM
Using visuo-kinetic virtual reality to induce illusory spinal movement: the MoOVi Illusion.

PeerJ

Harvie DS, Smith RT, Hunter EV, Davis MG, Sterling M, Moseley GL.
PMID: 28243537
PeerJ. 2017 Feb 22;5:e3023. doi: 10.7717/peerj.3023. eCollection 2017.

BACKGROUND: Illusions that alter perception of the body provide novel opportunities to target brain-based contributions to problems such as persistent pain. One example of this, mirror therapy, uses vision to augment perceived movement of a painful limb to treat...

Cite
Harvie DS, Smith RT, Hunter EV, et al. Using visuo-kinetic virtual reality to induce illusory spinal movement: the MoOVi Illusion. PeerJ. 2017;5:e3023doi: 10.7717/peerj.3023.
Harvie, D. S., Smith, R. T., Hunter, E. V., Davis, M. G., Sterling, M., & Moseley, G. L. (2017). Using visuo-kinetic virtual reality to induce illusory spinal movement: the MoOVi Illusion. PeerJ, 5e3023. https://doi.org/10.7717/peerj.3023
Harvie, Daniel S, et al. "Using visuo-kinetic virtual reality to induce illusory spinal movement: the MoOVi Illusion." PeerJ vol. 5 (2017): e3023. doi: https://doi.org/10.7717/peerj.3023
Harvie DS, Smith RT, Hunter EV, Davis MG, Sterling M, Moseley GL. Using visuo-kinetic virtual reality to induce illusory spinal movement: the MoOVi Illusion. PeerJ. 2017 Feb 22;5:e3023. doi: 10.7717/peerj.3023. eCollection 2017. PMID: 28243537; PMCID: PMC5324774.
Copy Download .nbib Format: NLM
Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU.

Journal of neurosciences in rural practice

Mojumder DK, Patel S, Nugent K, Detoledo J, Kim J, Dar N, Wilms H.
PMID: 25883482
J Neurosci Rural Pract. 2015 Apr-Jun;6(2):208-15. doi: 10.4103/0976-3147.153229.

INTRODUCTION: Measurement of static pupillary size in the ICU is of importance in cases of acutely expanding intracranial mass lesions. The inaccuracies with subjective assessment of pupillary size by medical personnel preclude its use in emergent neurological situations.OBJECTIVE: To...

Cite
Mojumder DK, Patel S, Nugent K, et al. Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU. J Neurosci Rural Pract. 2015;6(2):208-15doi: 10.4103/0976-3147.153229.
Mojumder, D. K., Patel, S., Nugent, K., Detoledo, J., Kim, J., Dar, N., & Wilms, H. (2015). Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU. Journal of neurosciences in rural practice, 6(2), 208-15. https://doi.org/10.4103/0976-3147.153229
Mojumder, Deb Kumar, et al. "Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU." Journal of neurosciences in rural practice vol. 6,2 (2015): 208-15. doi: https://doi.org/10.4103/0976-3147.153229
Mojumder DK, Patel S, Nugent K, Detoledo J, Kim J, Dar N, Wilms H. Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU. J Neurosci Rural Pract. 2015 Apr-Jun;6(2):208-15. doi: 10.4103/0976-3147.153229. PMID: 25883482; PMCID: PMC4387813.
Copy Download .nbib Format: NLM
ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial.

Geburtshilfe und Frauenheilkunde

Grischke EM, Röhm C, Hahn M, Helms G, Brucker S, Wallwiener D.
PMID: 26500370
Geburtshilfe Frauenheilkd. 2015 Sep;75(9):935-940. doi: 10.1055/s-0035-1557905.

No abstract available.

Cite
Grischke EM, Röhm C, Hahn M, et al. ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial. Geburtshilfe Frauenheilkd. 2015;75(9):935-940doi: 10.1055/s-0035-1557905.
Grischke, E. M., Röhm, C., Hahn, M., Helms, G., Brucker, S., & Wallwiener, D. (2015). ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial. Geburtshilfe und Frauenheilkunde, 75(9), 935-940. https://doi.org/10.1055/s-0035-1557905
Grischke, E-M, et al. "ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial." Geburtshilfe und Frauenheilkunde vol. 75,9 (2015): 935-940. doi: https://doi.org/10.1055/s-0035-1557905
Grischke EM, Röhm C, Hahn M, Helms G, Brucker S, Wallwiener D. ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial. Geburtshilfe Frauenheilkd. 2015 Sep;75(9):935-940. doi: 10.1055/s-0035-1557905. PMID: 26500370; PMCID: PMC4596694.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 474 entries